These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Design and synthesis of heterocyclic malonyl-CoA decarboxylase inhibitors.
    Author: Cheng JF, Chen M, Liu B, Hou Z, Arrhenius T, Nadzan AM.
    Journal: Bioorg Med Chem Lett; 2006 Feb; 16(3):695-700. PubMed ID: 16257202.
    Abstract:
    We have previously reported the discovery of small molecule inhibitors of malonyl-CoA decarboxylase (MCD) as novel metabolic modulators, which inhibited fatty acid oxidation and consequently increased the glucose oxidation rates in the isolated working rat hearts. MCD inhibitors were also shown to improve cardiac efficiency in rat and pig demand-induced ischemic models through the mechanism-based modulation of energy metabolism. Herein, we describe the design and synthesis of a series of novel heterocyclic MCD inhibitors with a preference for substituted imidazole and isoxazole.
    [Abstract] [Full Text] [Related] [New Search]